survivin Cancer Research Results
survivin, BIRC5: Click to Expand ⟱
| Source: |
| Type: antiapoptosis protein |
Survivin, BIRC5 (Baculoviral IAP Repeat Containing 5) is a potent anti-apoptosis protein that is differentially expressed in cancer and therefore constitutes an important anti-cancer target [49]. Moreover, high expression of survivin plays important role in resistance to chemo- and radiotherapy and has been shown to be related to unfavorable outcome for medulloblastomas.
"Survivin" is a protein that plays a crucial role in regulating cell division and inhibiting apoptosis (programmed cell death). It is part of the inhibitor of apoptosis (IAP) family and is often overexpressed in various types of cancer.
|
Scientific Papers found: Click to Expand⟱
NF-kB↓, Bcl-2↓, Casp3↑, survivin↑, TumCG↓,
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Cell Death ⓘ
Bcl-2↓, 1, Casp3↑, 1, survivin↑, 1,
Proliferation, Differentiation & Cell State ⓘ
TumCG↓, 1,
Immune & Inflammatory Signaling ⓘ
NF-kB↓, 1,
Total Targets: 5
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: survivin, BIRC5
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:299 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page